Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000596799 | SCV000707581 | uncertain significance | not provided | 2017-04-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002532576 | SCV003461988 | benign | Primary ciliary dyskinesia | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002532576 | SCV005991038 | uncertain significance | Primary ciliary dyskinesia | 2025-02-18 | criteria provided, single submitter | clinical testing | The c.10041T>A (p.N3347K) alteration is located in exon 62 (coding exon 62) of the DNAH11 gene. This alteration results from a T to A substitution at nucleotide position 10041, causing the asparagine (N) at amino acid position 3347 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |